Robert Williams, Jr. Sells 7,000,000 Shares of Aveanna Healthcare (NASDAQ:AVAH) Stock

Aveanna Healthcare Holdings Inc. (NASDAQ:AVAH) major shareholder Robert Williams, Jr. sold 7,000,000 shares of Aveanna Healthcare stock in a transaction dated Wednesday, June 3rd. The shares were sold at an average price of $6.24, for a total transaction of $43,680,000.00. Following the sale, the insider owned 252,899 shares of the company’s stock, valued at $1,578,089.76. The trade was a 96.51% decrease in their position. The sale was disclosed in a filing with the Securities & Exchange Commission, which can be accessed through the SEC website. Major shareholders that own at least 10% of a company’s stock are required to disclose their transactions with the SEC.

Aveanna Healthcare Trading Up 0.8%

Shares of AVAH opened at $6.68 on Friday. Aveanna Healthcare Holdings Inc. has a 1-year low of $3.73 and a 1-year high of $10.32. The company has a 50-day moving average of $6.79 and a 200 day moving average of $7.72. The firm has a market capitalization of $1.45 billion, a price-to-earnings ratio of 5.66, a PEG ratio of 0.75 and a beta of 1.93. The company has a debt-to-equity ratio of 5.35, a current ratio of 1.47 and a quick ratio of 1.47.

Aveanna Healthcare (NASDAQ:AVAH) last posted its quarterly earnings results on Thursday, May 14th. The company reported $0.18 EPS for the quarter, beating the consensus estimate of $0.13 by $0.05. Aveanna Healthcare had a net margin of 10.37% and a return on equity of 124.68%. The business had revenue of $647.92 million during the quarter, compared to analyst estimates of $613.22 million. The company’s quarterly revenue was up 15.9% on a year-over-year basis. On average, research analysts expect that Aveanna Healthcare Holdings Inc. will post 0.6 EPS for the current year.

Institutional Inflows and Outflows

A number of institutional investors and hedge funds have recently modified their holdings of the company. Segall Bryant & Hamill LLC grew its position in shares of Aveanna Healthcare by 425.8% in the 1st quarter. Segall Bryant & Hamill LLC now owns 163,966 shares of the company’s stock worth $1,056,000 after buying an additional 132,779 shares during the last quarter. Bank of America Corp DE grew its position in shares of Aveanna Healthcare by 64.2% in the 1st quarter. Bank of America Corp DE now owns 402,510 shares of the company’s stock worth $2,592,000 after buying an additional 157,368 shares during the last quarter. Smith Group Asset Management LLC grew its position in shares of Aveanna Healthcare by 34.3% in the 1st quarter. Smith Group Asset Management LLC now owns 263,669 shares of the company’s stock worth $1,698,000 after buying an additional 67,393 shares during the last quarter. EverSource Wealth Advisors LLC grew its position in shares of Aveanna Healthcare by 22.1% in the 1st quarter. EverSource Wealth Advisors LLC now owns 17,552 shares of the company’s stock worth $113,000 after buying an additional 3,172 shares during the last quarter. Finally, The Manufacturers Life Insurance Company grew its position in shares of Aveanna Healthcare by 56.3% in the 1st quarter. The Manufacturers Life Insurance Company now owns 36,509 shares of the company’s stock worth $235,000 after buying an additional 13,155 shares during the last quarter. Hedge funds and other institutional investors own 87.96% of the company’s stock.

Analysts Set New Price Targets

Several equities research analysts have recently commented on AVAH shares. Weiss Ratings lowered shares of Aveanna Healthcare from a “buy (b-)” rating to a “hold (c+)” rating in a report on Monday, April 6th. BMO Capital Markets reduced their price target on shares of Aveanna Healthcare from $11.00 to $10.00 and set an “outperform” rating for the company in a report on Friday, March 20th. Barclays reduced their price target on shares of Aveanna Healthcare from $9.50 to $9.00 and set an “overweight” rating for the company in a report on Monday, May 18th. Raymond James Financial upgraded shares of Aveanna Healthcare from an “outperform” rating to a “strong-buy” rating and set a $13.00 price target for the company in a report on Friday, March 20th. Finally, Stephens upgraded shares of Aveanna Healthcare from an “equal weight” rating to an “overweight” rating and boosted their price target for the company from $10.00 to $11.00 in a report on Friday, May 15th. One equities research analyst has rated the stock with a Strong Buy rating, six have issued a Buy rating and five have issued a Hold rating to the company’s stock. Based on data from MarketBeat.com, Aveanna Healthcare presently has an average rating of “Moderate Buy” and a consensus price target of $10.50.

About Aveanna Healthcare

Aveanna Healthcare, Inc (NASDAQ: AVAH) is a national provider of in-home health care services, specializing in pediatric skilled nursing, therapy, and related support for medically complex and chronically ill children. The company delivers a range of clinical and therapeutic solutions designed to enable patients to receive care in the comfort of their own homes, reducing the need for hospital stays and long-term institutional care. Aveanna’s offerings include registered nursing, physical, occupational and speech therapy, behavioral health counseling, and durable medical equipment coordination.

In addition to pediatric home health services, Aveanna operates adult home health and personal care support programs, assisting elderly and disabled adults with daily living activities, medication management, and rehabilitation therapies.